RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LVTX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Lava Therapeutics B.V.
(Updated on Jul 03, 2024)

Sell candidate since May 14, 2024 Loss -37.72% PDF

The Lava Therapeutics B.V. stock price fell by -4.76% on the last day (Wednesday, 3rd Jul 2024) from $1.89 to $1.80. During the last trading day the stock fluctuated 7.99% from a day low at $1.79 to a day high of $1.93. The price has risen in 6 of the last 10 days but is still down by -7.69% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 thousand shares and in total, 42 thousand shares were bought and sold for approximately $75.01 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.74 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -35.23% during the next 3 months and, with a 90% probability hold a price between $1.13 and $1.52 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LVTX Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, June 28, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lava Therapeutics B.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.86 and $2.28. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Lava Therapeutics B.V. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.143 between high and low, or 7.99%. For the last week the stock has had daily average volatility of 11.10%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LVTX) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Lava Therapeutics B.V. to open at $1.84, and during the day (based on 14 day Average True Range), to move between $1.60 and $2.00, which gives a possible trading interval of +/-$0.204 (+/-11.33%) up or down from last closing price. If Lava Therapeutics B.V. takes out the full calculated possible swing range there will be an estimated 22.65% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.94, some $0.140 (7.78%) from the current price of $1.80, our system finds the risk reward not very attractive.

Is Lava Therapeutics B.V. stock A Buy?

Lava Therapeutics B.V. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.702 Sell Candidate Unchanged

Predicted Opening Price for Lava Therapeutics B.V. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$1.84 ( 2.28%) $1.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LVTX

Fibonacci Support & Resistance Levels

Level Price
R3 1.98 10.22%
R2 1.93 7.19%
R1 1.90 5.31%
Price 1.80
S1 1.79 -0.757%
S2 1.75 -2.63%
S3 1.70 -5.67%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.09 16.11%
R2 1.97 9.44%
R1 1.94 7.78%
Price 1.80
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Lava Therapeutics B.V. Stock and on which exchange is it traded?
The symbol for Lava Therapeutics B.V. is LVTX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lava Therapeutics B.V. Stock?
Lava Therapeutics B.V. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lava Therapeutics B.V. Stock?
Lava Therapeutics B.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lava Therapeutics B.V. Stock.

What's the current price of Lava Therapeutics B.V. Stock?
As of the end of day on the Jul 03, 2024, the price of an Lava Therapeutics B.V. (LVTX) share was $1.80.

What is the 52-week high and low for Lava Therapeutics B.V. Stock?
The 52-week high for Lava Therapeutics B.V. Stock is $6.47 and the 52-week low is $1.13.

What is the market capitalization of Lava Therapeutics B.V. Stock?
As of the Jul 03, 2024, the market capitalization of Lava Therapeutics B.V. is 47.326M.

When is the next earnings date for Lava Therapeutics B.V.?
The upcoming earnings date for Lava Therapeutics B.V. is Aug 27, 2024.
Click to get the best stock tips daily for free!

About Lava Therapeutics B.V.

Lava Therapeutics B.V. LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for b... LVTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT